Loading chat...
IL HB2631
Bill
Status
Failed
1/7/2025
Primary Sponsor
Marcus Evans
Click for details
AI Summary
- Amends the Illinois Public Aid Code to add Section 5-5.12f regarding hepatitis C treatment medications
- Prohibits prior authorization mandates on FDA-approved direct-acting antivirals for hepatitis C treatment that are listed as preferred on the Illinois Medicaid Preferred Drug List
- Prohibits utilization management controls on these preferred hepatitis C medications under both fee-for-service and managed care medical assistance programs
- Aims to remove barriers to timely and equitable treatment of hepatitis C in Illinois Medicaid
Legislative Description
MEDICAID-HEPATITIS C-TREATMENT
Last Action
Session Sine Die
1/7/2025
Committee Referrals
Rules5/19/2023
Medicaid & Managed Care3/9/2023
Appropriations-Health & Human Services2/28/2023
Rules2/15/2023
Full Bill Text
No bill text available